BACKGROUND: Early (e')/late (a') diastolic mitral annular velocity ratio is a powerful independent predictor of poor prognosis in patients with left ventricular (LV) dysfunction. Doppler tissue imaging, however, may change over time according to intervention and medical treatment. The aim of the present study was to prospectively evaluate whether, in clinically stable patients with chronic heart failure (CHF), the decrease of an initially high e'/a' ratio on long-term therapy predicts a more favorable outcome. METHODS AND RESULTS: One hundred and eighty-one adult patients with CHF and high e'/a' ratio (≥ 0.74) underwent repeat echocardiography 6 months after the initial examination, and were then followed up for a mean period of 20 months. After 6 months, e'/a' ratio did not change in 95 patients, whereas it was significantly decreased (<0.74) in the remaining 86 patients. During follow-up, 55 participants (30%) had cardiac events. According to multivariate Cox regression analysis, decrease in e'/a' ratio, initial New York Heart Association class III or IV, and change in LV mass index as well as in systolic mitral annular velocities emerged as independent predictors of survival. CONCLUSIONS: The decrease of an initially high e'/a' ratio on long-term therapy predicts a more favorable outcome in clinically stable patients with CHF.
BACKGROUND: Early (e')/late (a') diastolic mitral annular velocity ratio is a powerful independent predictor of poor prognosis in patients with left ventricular (LV) dysfunction. Doppler tissue imaging, however, may change over time according to intervention and medical treatment. The aim of the present study was to prospectively evaluate whether, in clinically stable patients with chronic heart failure (CHF), the decrease of an initially high e'/a' ratio on long-term therapy predicts a more favorable outcome. METHODS AND RESULTS: One hundred and eighty-one adult patients with CHF and high e'/a' ratio (≥ 0.74) underwent repeat echocardiography 6 months after the initial examination, and were then followed up for a mean period of 20 months. After 6 months, e'/a' ratio did not change in 95 patients, whereas it was significantly decreased (<0.74) in the remaining 86 patients. During follow-up, 55 participants (30%) had cardiac events. According to multivariate Cox regression analysis, decrease in e'/a' ratio, initial New York Heart Association class III or IV, and change in LV mass index as well as in systolic mitral annular velocities emerged as independent predictors of survival. CONCLUSIONS: The decrease of an initially high e'/a' ratio on long-term therapy predicts a more favorable outcome in clinically stable patients with CHF.
Authors: Maria Dons; Tor BieringSørensen; Jan Skov Jensen; Thomas Fritz-Hansen; Jan Bech; Martina Chantal de Knegt; Jacob Sivertsen; Flemming Javier Olsen; Rasmus Mogelvang Journal: J Atr Fibrillation Date: 2015-06-30
Authors: Alexander C Razavi; Lydia A Bazzano; Jiang He; Camilo Fernandez; Seamus P Whelton; Marie Krousel-Wood; Shengxu Li; Jovia L Nierenberg; Mengyao Shi; Changwei Li; Xuenan Mi; Jason Kinchen; Tanika N Kelly Journal: J Am Heart Assoc Date: 2020-01-29 Impact factor: 5.501
Authors: Alexander C Razavi; Lydia A Bazzano; Jiang He; Seamus P Whelton; Camilo Fernandez; Sylvia Ley; Lu Qi; Marie Krousel-Wood; Timothy S Harlan; Tanika N Kelly Journal: ESC Heart Fail Date: 2020-07-10